|
|
||||||||
Ann Thorac Surg 1988;46:362-365
© 1988 The Society of Thoracic Surgeons
From the Department of Medicine, Indiana University Medical Center, Indianapolis, IN
* Address reprint requests to Dr. Einhorn, Department of Medicine, Hematology/Oncology, Indiana University Medical Center, 926 West Michigan, UH A109, Indianapolis, IN 46223.
During the past several years, there has been a resurgence of interest in preoperative or postoperative chemotherapy in patients with Stage III lung cancer.
The staging system for lung cancer has recently been modified, and at the present time Stage III disease is now subdivided into Stage III-A (potentially surgically resectable for cure) and Stage III-B (unresectable). This article will review five recently completed studies utilizing neo-adjuvant therapy in various types of Stage III lung cancer. The thoracic surgeon is faced with the dilemma of reviewing this literature and trying to make a conclusion as to what is appropriate therapy for Stage III disease. Unquestionably, neoadjuvant therapy appears to increase the re-sectability rate in Stage III-A disease and can make some Stage III-B patients anatomically resectable. It is hoped that future well-designed phase III studies can be accomplished in Stages III-A and III-B disease so that we can determine whether neoadjuvant chemotherapy is or is not beneficial for these patients.
This article has been cited by other articles:
![]() |
H. Wada, R. Miyahara, F. Tanaka, S. Hitomi, and West Japan Study Group for lung cancer surgery (WJ Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial Eur J Cardiothorac Surg, April 1, 1999; 15(4): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Einhorn Neoadjuvant and Adjuvant Trials in Non-Small Cell Lung Cancer Ann. Thorac. Surg., January 1, 1998; 65(1): 208 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Miller, L. A. Gorenstein, and G. A. Patterson Staging: The key to rational management of lung cancer Ann. Thorac. Surg., January 1, 1992; 53(1): 170 - 178. [Abstract] [PDF] |
||||
![]() |
W. S. Pierce Cardiothoracic Surgery JAMA, May 19, 1989; 261(19): 2827 - 2829. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |